By George W. Chapman The recent requirement for hospitals to post their prices for 300 “shoppable” services, discussed here in earlier columns, has revealed
Healthcare in a Minute
2020 Leading Causes of Death (COVID-19 Doesn’t Top the List)
By George W. Chapman COVID-19 was the No. 3 cause of death behind heart disease and cancer. Early in the pandemic, naysayers believed COVID-19 would
Private Practices Continue to Shrink in Numbers
By George W. Chapman The number of physicians in private practice continues to decline. According to an AMA survey of 3,500 physicians, 49% responded
COVID-19 Relief and ACA
By George W. Chapman Passed in March, the $1.9 trillion package afforded more relief to people living at poverty levels who are insured through
COVID-19: Experts Believe Virus is Here to Stay
COVID-19: Experts Believe Virus is Here to Stay By George W. Chapman The FDA will expedite the review process for manufacturers developing updates and
Big Pharma Wins if Senate Remains Controlled by Republicans
By George W. Chapman A Democratic president will have minimal to no impact on any attempt to reign in drug prices if Republicans retain
COVID-19 Vaccine: Providers, First Responders Among the First to Get It
By George W. Chapman The FDA has made clear it will not take potentially dangerous short cuts when granting emergency authorization to vaccine producers.
Presidential Candidates’ Misleading Messages About Drug Prices
By George W. Chapman Elections are just around the corner and political ads, national and local, are rife with claims that their candidate is
Profits for Major Insurers Double This Year. Does it Mean We Will Get a Premium Rebate?
By George W. Chapman The short answer is: don’t hold your breath. A recent article in the New York Times by Reed Abelson explained.
Hospitals Struggling Big Time
By George W. Chapman What tends to get lost in all the headline-grabbing news related to the pandemic (PPE shortages, morbidity, testing, lingering long

